newsfilter
← Latest News
ACCESS Newswire·

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds

SEATTLE, WASHINGTON / ACCESSWIRE / December 12, 2024 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel